Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LNZ101 and LNZ100 Ophthalmic Solutions for Presbyopia
CTR20232913Phase 3Completed
- Sponsor
- LENZ Therapeutics
- Start
- Sep 2023
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of LNZ101, aceclidine in presbyopia, sponsored by LENZ Therapeutics. Started Sep 2023; status: completed.
02
Drugs
LNZ101aceclidine
03
Conditions
presbyopia
Beyond the preview
Go deeper on CTR20232913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232913.